While your control tower can likely see the problem, it still cannot fix it. A decade of logistics platforms promised to transform healthcare supply chains, and most delivered the same thing: a better dashboard. When a cell therapy shipment misses its connecting flight, the dashboard shows the delay, but an individual still calls the courier, waits on hold, reroutes the product, manages the clinical site, and documents the deviation, all while the viability window closes. Visibility was the promise. Phone calls, emails, and manual work are still the reality.

The gap between complexity and capacity is widening fast. As of 2025, Biologics have overtaken small molecules in terms of value. Biologics are projected to account for 57% of global prescription drug sales by 2030¹. The IQVIA Institute estimated that the biopharma industry loses approximately $35 billion annually as a result of failures in temperature-controlled logistics.^{2 3}

A new architecture closes that gap. AI-native platforms provide capabilities that enable the system to be the first responder: voice agents that call courier operations lines, email agents that notify sites and recipients, no-code workflows that turn SOPs into executed, audited sequences with every action logged to a 21 CFR Part 11-compliant chain of custody. Before AI, the best-run operations resolved 10-15% of incidents without a human-in-the-loop.⁴ Today, deployments of AI-native operating platforms are achieving 50%-70% auto-resolution of alerts, 74% shorter delays, and quality reviews decreased by three days.⁴

So, the right question for any platform isn't "Does it show me everything?" It's "What percentage of exceptions does it correctly resolve without needing a human-in-the loop?"

The past decade has produced a generation of "logistics control towers" that promised to transform pharmaceutical and healthcare supply chain operations. Most have delivered a better dashboard with improved visibility, some have delivered predictive risk models that surface potential deviations. What they have not delivered is fewer phone calls, fewer escalations, and fewer missed deliveries.

The problem is structural. The dominant architecture of these platforms was built to aggregate data from carrier portals, sensor platforms, and ERPs into a single screen. That is useful. But aggregation and action are two different things. A consolidated view of a flight delay still requires a human to collect relevant information related to possible options, weigh those options based on risk, time, cost—and then decide what to do.

In the meantime, shipment volumes in healthcare and life sciences are generally growing faster than the operations teams that manage them. Biologics, which require cold chain logistics, are projected to account for 57% of pharmaceutical sales by 2030.¹ The result is a widening gap between the growing complexity of the logistics operations required for these advanced therapies and the capacity of the teams responsible for getting it to the appropriate location on-time.

A new generation of AI-native logistics platforms is closing that gap, built on technology that didn't exist two years ago.

The term "control tower" entered healthcare logistics roughly fifteen years ago, borrowed from aerospace and general freight. The concept was straightforward: instead of checking five carrier portals and two sensor dashboards to understand the status of your shipments, data would be aggregated into a consolidated view.

For a small operations team managing a few hundred shipments a month, this was transformative. For a team managing tens of thousands of shipments across multiple couriers, various sensor technology and vendors, clinical trial sites, and patients, the consolidated view has become the floor, not the ceiling. The problem isn't visibility. It is how to effectively respond to the alerts that actually matter in a timely manner.

Consider a scenario familiar to anyone who manages clinical supply logistics. A cell therapy shipment is en route from a manufacturing site in Los Angeles to a clinical site in Kansas City. The courier hasn't updated the tracking portal since pickup. The flight that was supposed to carry the package has been delayed. The logistics coordinator, checking the control tower dashboard, can see the delay. What happens next is entirely manual: someone calls the courier's operations line, waits on hold, escalates, potentially sources an alternative solution, calls the site to manage expectations, and documents the deviation in the quality system. This is all happening while the product's viability window continues to close.

The dashboard didn't solve the problem. It just made the problem visible.

The term "AI-powered" has become nearly universal in logistics software marketing. For logistics leaders making purchasing decisions, the distinction that matters is not whether a platform uses AI. It is whether the platform was architecturally designed around AI from the beginning, or whether AI capabilities were added to an existing visibility product.

AI-bolted-on: the upgrade problem

Most first-generation logistics platforms were built to display data. AI features added later were typically a predictive ETA layer, a risk scoring overlay, or a chatbot interface sitting on top of an architecture that was never designed to support autonomous action. The AI got better at telling you what was wrong. The process of fixing it did not change.

AI-native: action as the default

An AI-native platform is built with the assumption that the system, not the human, should be the first responder to any exception. In the integration layer, AI-native platforms go beyond read-only API access to carrier and sensor data. They maintain active communication channels: voice AI that can call courier operations lines, email agents that can send and interpret responses, webhook connections that log outcomes back into the chain of custody automatically.

The question shifts from "What is the status of my shipments?" to "What do I actually need to decide today?"

For most of the past decade, healthcare logistics performance has been measured primarily through on-time delivery rate. This is a useful metric. But it is a lagging indicator that tells you what happened, not how efficiently your team handled what happened.

The metric that captures the difference is the zero-touch exception resolution rate: the percentage of shipment exceptions that are identified, actioned, resolved, and documented without requiring any human intervention.

Why this metric was not trackable before

In first-generation logistics platforms, zero-touch rate was meaningless. The platform could not resolve exceptions, so every exception required human action by definition. AI-native platforms change the denominator. Early results in pharmaceutical logistics suggest that zero-touch rates of 50% or higher are achievable for the most common exception types.

The healthcare and life sciences industry is at an inflection point in logistics technology. AI-native logistics platforms that can autonomously execute exception resolution—not just surface alerts, but make calls, send updates, log outcomes, and escalate only what actually requires judgment—represent a structural change in what is possible.

The right question for logistics leaders evaluating any platform is not "Does it show me everything?" It is: "What percentage of exceptions not requiring escalation for human judgment does it resolve without my team's involvement?"